Singapore: Australia firm focused on sleep disorder, ResMed, has completed the previously announced acquisition of China based Curative Medical, a provider of non-invasive ventilation and sleep-disordered breathing medical devices and accessories.

"By joining forces with Curative Medical we expand our combined reach in the growing respiratory medical device market in China," said Mr Mick Farrell, CEO, ResMed. "Together we will focus on improving patient quality of life while reducing the cost of care for sleep-disordered breathing and chronic obstructive pulmonary disease."

The company informed that ResMed China and Curative Medical will remain operationally independent, and Curative will continue to invest in R&D, manufacturing, marketing and sales teams in China.

Curative will continue to maintain its name, brands, and innovative offerings tailored for the Chinese market and other global markets, and will be strategically positioned to target different customer segments than ResMed. Curative employees, including the founder and chief executive officer, Mr Jason Sun, will continue as employees of the combined ResMed and Curative team.